Mice with global Scd1 deletion or that are treated with anti-Scd1 oligonucleotides are resistant to high-fat diet (HFD)-induced obesity and do not develop insulin resistance. The gene discussed is SCD; the disease is obesity due to melanocortin 4 receptor deficiency.